|
|
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
4/24/2012 | published by: Venture Planning Group
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business
|
more...
|
$18,500.00
|
|
2012 Global Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
4/23/2012 | published by: Venture Planning Group
This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. Highlights Business and technological trends in seven major
|
more...
|
$28,500.00
|
|
Global RNAi Market Analysis
4/1/2012 | published by: RNCOS
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications for various indications, and aids
|
more...
|
$1,300.00
|
|
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
1/1/2012 | published by: Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at
|
more...
|
$3,500.00
|
|
Genetic Testing
2/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate
|
more...
|
$4,500.00
|
|
Cell-Based Assays: World Market Prospects 2012-2022
1/23/2012 | published by: Visiongain
What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions.
Our study analyses products and services for cell-based
|
more...
|
$2,642.00
|
|
Personalized Medicine Market Analysis
1/1/2012 | published by: RNCOS
With the increasing knowledge of human DNA, a new segment called personalized medicines has emerged in the healthcare industry, which includes therapeutics, diagnostics, and theranostics tailored towards the treatment or prevention of disease. Even though
|
more...
|
$1,200.00
|
|
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
1/9/2012 | published by: GlobalData
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Summary GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on
|
more...
|
$2,500.00
|
|
Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
2/14/2012 | published by: Venture Planning Group
This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. Highlights Business and technological trends in seven major
|
more...
|
$28,500.00
|
Related Markets
Antisense & RNAi Technology Reports
- 2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
- 2012 US Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
- 2012 UK Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
- 2012 Spain Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
- 2012 Japan Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
